DNA adduct levels and intestinal lesions in congenic rapid and slow acetylator Syrian hamsters administered the food mutagens 2-amino-1-methyl-6- phenylimidazo[4,5b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5f]quinoline (IQ)

Pharmacology and Toxicology

Volumn 86, Issue 6, 2000, Pages 257-263

  Steffensen, Inger Lise ^a   Fretland, Adrian J ^b,c   Paulsen, Jan Erik ^a   Feng, Yi ^b,c   Eide, Tor Jacob ^d   Devanaboyina, Udaya Sankar ^c   Hein, David W ^b,c   Alexander, Jan ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Univ of N Dakota Sch of Medicine   (United States)

^c University of Louisville School of Medicine   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; MUTAGENIC AGENT;

ACETYLATOR PHENOTYPE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; DNA ADDUCT; FEMALE; GENE LOCUS; GENOTYPE; INTESTINE TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER;

EID: 0034095732     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0901-9928.2000.860603.x     Document Type: Article

References (61)

1. Alexander, J., B. H. Fossum & J. A. Holme: Metabolism of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in isolated liver cells from guinea pig, hamster, mouse, and rat. Environ. Health Perspect. 1994, 102, 109-114.
2. Alexander, J. & H. Wallin: Metabolic fate of heterocyclic amines from cooked food. In: Mutagens in food: Detection and prevention. Ed.: H. Hayatsu. CRC Press, Boca Raton, Florida, USA, 1991, pp. 143-156.
3. Bird, R. P.: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987, 37, 147-151.
4. Blum, M., D. M. Grant, W. McBride, M. Heim & U. A. Meyer: Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 1990, 9, 193-203.
5. Chen, J., M. J. Stampfer, H. L. Hough, M. Garcia-Closas, W. C. Willett, C. H. Hennekens, K. T. Kelsey & D. J. Hunter: A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res. 1998, 58, 3307-3311.
6. Delclos, K. B. & F. F. Kadlubar: Carcinogenic aromatic amines and amides. In: Comprehensive toxicology. Eds.: I. G. Sipes, C. A. McQueen & A. J. Gandolfi. Elsevier Science Ltd., Oxford, UK, 1997, pp. 141-170.
7. Esumi, H., H. Ohgaki, E. Kohzen, S. Takayama & T. Sugimura: Induction of lymphoma in CDF, mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jap. J. Cancer Res. 1989, 80, 1176-1178.
8. Evans, D. A. P.: N-acetyltransferase. Pharmacol. Therap. 1989, 42, 157-234.
9. Feng, Y., A. J. Fretland, T. D. Rustan, W. Jiang, W. K. Becker & D. W. Hein: Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2′-dimethyl-4-aminobiphenyl. Toxicol. Appl. Pharmacol. 1997, 147, 56-62.
10. Feng, Y., R. J. Wagner, A. J. Fretland, W. K. Becker, A. M. Cooley, T. P. Pretlow, K. J. Lee & D. W. Hein: Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2′-dimethyl-4-aminobiphenyl. Cancer Res. 1996a, 56, 527-531.
11. Feng, Y, W. Jiang, A. C. Deitz & D. W. Hein: 3,2′-Dimethyl-4-aminobiphenyl-DNA adduct formation in tumor target and non-target organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus. Toxicol. Appl. Pharmacol. 1996b, 140, 315-321.
12. Ferguson, R. J., M. A. Doll, B. R. Baumstark & D. W. Hein: Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters. Gene 1994a 140, 247-249.
13. Ferguson, R. J., M. A. Doll, T. D. Rustan, B. R. Baumstark & D. W. Hein: Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli. Pharmacogenetics 1994b, 4, 82-90.
14. Ferguson, R. J., M. A. Doll, T. D. Rustan & D. W. Hein: Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyltransferase encoding genes of the Syrian hamster. Pharmacogenetics 1996, 6, 55-66.
15. Fiala, E. S., J. H. Weisburger, S. Katayama, V. Chandrasekaran & G. M. Williams: The effect of disulfiram on the carcinogenicity of 3,2′-dimethyl-4-aminobiphenyl in Syrian golden hamsters and rats. Carcinogenesis 1981, 2, 965-969.
16. Grant, D. M.: Molecular genetics of the N-acetyltransferases. Pharmacogenetics 1993, 3, 45-50.
17. Grant, D. M., M. Blum, M. Beer & U. A. Meyer: Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 1991, 39, 184-191.
18. Hanna, P. E.: N-Acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. Adv. Pharmacol. 1994, 27, 401-430.
19. Hasegawa, R., M. Sano, S. Tamano, K. Imaida, T. Shirai, M. Nagao, T. Sugimura & N. Ito. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenicity in rats. Carcinogenesis 1993, 14, 2553-2557.
20. Hein, D. W.: Acetylator genotype and arylamine-induced Carcinogenesis. Biochim. Biophys. Acta 1988, 948, 37-66.
21. Hein, D. W.: A new model for toxic risk assessments: construction of homozygous rapid and slow acetylator congenic Syrian hamster lines. Toxicol. Methods 1991, 1, 44-52.
22. Hein, D. W., M. A. Doll, A. J. Fretland, K. Gray, A. C. Deitz, Y. Feng, W. Jiang, T. D. Rustan, S. L. Satran & T. R. Wilkie, Sr.: Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. Mutat. Res. 1997a, 376, 101-106.
23. Hein, D. W., M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju & Y. Feng: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 29-42.
24. Hein, D. W., M. A. Doll, K. Gray, T. D. Rustan & R. J. Ferguson: Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res. 1993a, 53, 509-514.
25. Hein, D. W., M. A. Doll, T. D. Rustan, K. Gray, R. J. Ferguson & Y. Feng: Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N-and O-acetylation of arylamine carcinogens. Toxicol. Appl. Pharmacol. 1994, 124, 16-24.
26. Hein, D. W., M. A. Doll, T. D. Rustan, K. Gray, Y. Feng, R. J. Ferguson & D. M. Grant: Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 1993b, 14, 1633-1638.
27. Hein, D. W., R. J. Ferguson, M. A. Doll & A. C. Deitz: Recombinant expression and catalytic analysis of rapid and slow acetylator Syrian hamster chimeric NAT2 alleles. Arch. Toxicol. 1997b, 71, 306-313.
28. Mein, D. W., W. G. Kirlin, R. J. Ferguson & W. W. Weber: Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Therap. 1985, 234, 358-364.
29. Ito, N., R. Hasegawa, M. Sano, S. Tamano, H. Esumi, S. Takayama & T. Sugimura: A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1991, 12, 1503-1506.
30. Jiang, W., Y. Feng & D. W. Hein: Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2′-dimethyl-4-aminobiphenyl. Toxicol. Appl. Pharmacol. 1999, 156, 187-194.
31. Jones, R. F., S. J. Land & C. M. King: Recombinant rat and hamster N-acetyltransferases-1 and -2: relative rates of N-acetylation of arylamines and N,O-acyltransfer with arylhydroxamic acids. Carcinogenesis 1996, 17, 1729-1733.
32. Kadlubar, F. F., M. A. Butler, K. R. Kaderlik, H.-C. Chou & N. P. Lang: Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ. Health Perspect. 1992, 98, 69-74.
33. Lang, N. P., M. A. Butler, J. Massengill, M. Lawson, R. C. Stotts, M. Hauer-Jensen & F. F. Kadlubar: Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev. 1994, 3, 675-682.
34. Layton, D. W., K. T. Bogen, M. G. Knize, F. T. Hatch, V. M. Johnson & J. S. Felton: Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 1995, 16, 39-52.
35. Leff, M. A., P. N. Epstein, M. A. Doll, A. J. Fretland, U.-S. Devanaboyina, T. D. Rustan & D. W. Hein: Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse. J. Pharmacol. Exp. Therap. 1999, 290, 182-187.
36. Lin, D., K. R. Kaderlik, R. J. Turesky, D. W. Miller, J. O. Lay, Jr. & F. F. Kadlubar: Identification of N-(deoxyguanosin-8-y1)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. Chem. Res. Toxicol. 1992, 5, 691-697.
37. Lin, D.-X., N. P. Lang & F. F. Kadlubar: Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Dispos. 1995, 23, 518-524.
38. Nagao, M. & T. Sugimura: Carcinogenic factors in food with relevance to colon cancer development. Mutat. Res. 1993, 290, 43-51.
39. Nussbaum, M., E. S. Fiala, B. Kulkarni, K. El-Bayoumy & J. H. Weisburger: In vivo metabolism of 3,2′-dimethyl-4-aminobiphenyl (DMAB) bearing on its organotropism in the Syrian golden hamster and the F344 rat. Environ. Health Perspect. 1983, 49, 223-231.
40. Ochiai, M., K. Ogawa, K. Wakabayashi, T. Sugimura, S. Nagase, H. Esumi & M. Nagao: Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Nagase analbuminemic rats. Jap. J. Cancer Res. 1991, 82, 363-366.
41. Ohgaki, H., K. Kusama, N. Matsukura, K. Morino, H. Hasegawa, S. Sato, S. Takayama & T. Sugimura: Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 1984, 5, 921-924.
42. Ozawa, S., M. Abu-Zeid, Y. Kawakubo, S. Toyama, Y. Yamazoe & R. Kato: Monomorphic and polymorphic isozymes of arylamine N-acetyltransferases in hamster liver: purification of the isozymes and genetic basis of N-acetylation polymorphism. Carcinogenesis 1990, 11, 2137-2144.
43. Paulsen, J. E., I.-L. Steffensen, E. Namork, D. W. Hein & J. Alexander: Effect of acetylator genotype on 3,2′-dimethyl-4-aminobiphenyl induced aberrant crypt foci in the colon of hamsters. Carcinogenesis 1996, 17, 459-465.
44. Purewal, M., A. J. Fretland, H. A. J. Schut, D. W. Hein & M. J. Wargovich: Association between acetylator genotype and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats. Cancer Lett. 2000a, 149, 53-60.
45. Purewal, M., M. Velasco, A. J. Fretland, D. W. Hein & M. J. Wargovick: 2-Amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine induces a higher number of aberrant crypt foci in Fischer-344 (rapid) than Wistar Kyoto (slow) acetylator inbred rats. Cancer Epidemiol. Biomarkers Prev. 2000b, 9, in press.
46. Roberts-Thomson, I. C., P. Ryan, K. K. Khoo, W. J. Hart, A. J. McMichael & R. N. Butler: Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996, 347, 1372-1374.
47. Smith, T. J. & P. E. Hanna: N-Acetyltransferase multiplicity and the bioactivation of N-arythydroxamic acids by hamster hepatic and intestinal enzymes. Carcinogenesis 1986, 7, 697-702.
48. 32P-Postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx-and PhIP-treated monkeys. Carcinogenesis 1993, 14, 1389-1395.
49. Steffensen, I.-L., J. E. Paulsen & J. Alexander: Unexpected antagonistic action of 3,2′-dimethyl-4-aminobiphenyl on aberrant crypt induction by 1,2-dimethylhydrazine or azoxymethane in rat colon. Carcinogenesis 1995, 16, 2981-2988.
50. Steffensen, I.-L., J. E. Paulsen, T. J. Eide & J. Alexander: 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis 1997, 18, 1049-1054.
51. Takahashi, S., K. Ogawa, H. Ohshima, H. Esumi, N. Ito & T. Sugimura: Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jap. J. Cancer Res. 1991, 82, 135-137.
52. Takayama, S., Y. Nakatsuru, M. Masuda, H. Ohgaki, S. Sato & T. Sugimura: Demonstration of carcinogenicity in F344 rats of 2-amino-3-methylimidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Jap. J. Cancer Res. 1984, 75, 467-470.
53. Tanaka, T., W. S. Barnes, G. M. Williams & J. H. Weisburger: Multipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Jap. J. Cancer Res. 1985, 76, 570-576.
54. Tudek, B., R. P. Bird & W. R. Bruce: Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res. 1989, 49, 1236-1240.
55. Vatsis, K. P. & W. W. Weber: Acetyltransferases. In: Comprehensive toxicology. Eds.: I. G. Sipes, C. A. McQueen and A. J. Gandolfi. Elsevier Science Ltd., Oxford, UK, 1997, pp. 385-399.
56. Ware, J. A. & C. K. Svensson: Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Biochem. Pharmacol. 1996, 52, 1613-1620.
57. Weber, W. W. & D. W. Hein: N-Acetylation pharmacogenetics. Pharmacol. Rev. 1985, 37, 25-79.
58. Weisburger, J. H., A. Rivenson, J. Reinhardt, C. Aliaga, J. Braley, L. M. Dolan, G. M. Williams, E. Zang, D. G. I. Kingston, M. Bashir, Y.-Z. Shu, T. D. Wilkins & R. L. Van Tassell: Genotoxicity and carcinogenicity in rats and mice of 2-amino-3,6-dihydro-3-methyl-7H-imidazolo[4,5-f]quinolin-7-one: an intestinal bacterial metabolite of 2-amino-3-methyl-3H-imidazo[4,5-f]-quinoline. J. Natl. Cancer Inst. 1994, 86, 25-30.
59. Welfare, M. R., J. Cooper, M. F. Bassendine & A. K. Daly: Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England. Carcinogenesis 1997, 18, 1351-1354.
60. Wormhoudt, L. W., J. N. M Commandeur & N. P. E. Vermeulen: Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit. Rev. Toxicol. 1999, 29, 59-124.
61. Xu, M., A. C. Bailey, J. F. Hernaez, C. R. Taoka, H. A. J. Schut & R. H. Dashwood: Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f)quinoline-induced DNA adducts and colonie aberrant crypts in the F344 rat. Carcinogenesis 1996, 17, 1429-1434.